Dr Chia Lun (Mike) Wu is a Senior Research Fellow at the University of Sydney’s School of Biomedical Engineering. His research bridges biology, engineering, and clinical science, with a focus on translational R&D and the commercialization of new diagnostics and therapies for thrombotic complications in cardiovascular disease. He earned First-Class Honours and a Ph.D. in Immunopharmacology at the University of Queensland, complemented by training in research commercialization and patent development. With over a decade of experience in thrombosis and haemostasis, he has published in Nature and Science journals, and his discoveries have advanced understanding of red blood cell–driven microvascular thrombosis in stroke, diabetes, ischemia, infection, and cancer. Dr Wu has developed safer anticoagulants inspired by bush ticks and co-invented SmartClot+, a rapid paper-based blood test that won the 2025 PERIscope Commercialisation Prize. His projects are supported by major national grants, and he was awarded the Gordon Research Conference Young Investigator Award in 2025.